Fundraising Fox

Somite

Boston, US · Founded 2023 · Delaware corporation · 10 known investors

somite.ai ↗

Cellular Intelligence is a cell therapy company developing engineered cell treatments for diseases, including a Phase 2-ready therapy for Parkinson's disease acquired from Novo Nordisk. The company applies computational biology and synthetic biology approaches to reprogram cellular function.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

MB
Micha Breakstone, Ph.D.CEO & co-founder
AK
Allon Klein, Ph.D.Scientific Co-founder
OP
Olivier Pourquié, Ph.D.Scientific Co-founder
CT
Cliff Tabin, Ph.D.Scientific Co-founder
JS
Jay Shendure, M.D., Ph.D.Scientific Co-founder
MB
Micah BreakstoneCo-founder
CC
Chad CowanNamed on SEC filing

Board

SH
Steven HoltzmanBoard director

Investors · 10

Khosla VenturesMenlo Park · $5K – $50M
Next Coast VenturesAustin · $2M – $4M
Samsung NextSan Jose · $100K – $5M
AMD VenturesreportedSanta Clara
FusionreportedPalo Alto · $500K – $1M
Lerer HippeaureportedNew York · $500K – $2M
Montage VenturesreportedMenlo Park · $4M
Trust VenturesreportedAustin

Also in the syndicate · 2

TechAvivleadTexas Venture Partners

Funding

SEC filings, press & company announcements

$52.8M disclosed across 2 rounds · 2024–2025

▶$47.5MraisedNov 2025 · 30 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven HoltzmanDirector
  • Chad CowanDirector
  • Micah BreakstoneExecutive Officer, Director, Promoter
Offering amount
$47.5M
Amount sold
$47.5M
First sale
Apr 2025
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Somite.ai Announces Strategic Investment from AMD Ventures to Accelerate Foundation Models for Cell Therapyfinance.yahoo.com · Aug 2025Somite AI Raises $47M Series A To Reinvent Cell Replacement Therapyforbes.com · May 2025Somite AI Raises Series A Fundingfinsmes.com · May 2025Somite Therapeutics Raises $4.8M Extension of Pre-Seed Fundingfinsmes.com · Sep 2024Somite Raises $5.3M in Pre-Seed Fundingfinsmes.com · Apr 2024Somite Raises $5.3M As Five Leading Scientists Join Forces To Incorporate AI In Stem Cell Therapyprnewswire.com · Apr 2024

Frequently asked questions

What does Somite do?
Cellular Intelligence is a cell therapy company developing engineered cell treatments for diseases, including a Phase 2-ready therapy for Parkinson's disease acquired from Novo Nordisk. The company applies computational biology and synthetic biology approaches to reprogram cellular function.
Who founded Somite?
Somite was founded by Micha Breakstone, Ph.D., Allon Klein, Ph.D., Olivier Pourquié, Ph.D., Cliff Tabin, Ph.D., Jay Shendure, M.D., Ph.D., Micah Breakstone in 2023.
Who are Somite's investors?
Somite's investors include Khosla Ventures, Next Coast Ventures, Samsung Next, AMD Ventures, Fusion, Lerer Hippeau, Montage Ventures, Trust Ventures.
How much funding has Somite raised?
Somite has disclosed $52.8M raised across 2 rounds.
Where is Somite headquartered?
Somite is headquartered in Boston, US.